Janus Henderson Group PLC Neogenomics Inc Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 5,741,026 shares of NEO stock, worth $41.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,741,026
Previous 6,165,063
6.88%
Holding current value
$41.8 Million
Previous $102 Million
46.38%
% of portfolio
0.03%
Previous 0.05%
Shares
32 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$143 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$104 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$48.9 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$44 Million7.36% of portfolio
-
State Street Corp Boston, MA5.09MShares$37.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $916M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...